UBC researchers discover how cancer’s ‘invisibility cloak’ works
UBC researchers have discovered how cancer cells become invisible to the body’s immune system, a crucial step that allows tumours to metastasize and spread throughout the body.
Destructive disease shows potential as a cancer treatment
Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.
Cancer is not a game of roulette
The journal Science published an article last month that garnered far more attention than usually. In it, the authors made a provocative claim: two-thirds of the variation of cancer risk among different types of tissues can be attributed to random mutations, in other words, “bad luck.”
In Cancer’s Margins
When illness strikes, we turn to our healthcare system. But what if the medical system doesn’t acknowledge your gender identity?
Blue spotlight on a stealthy killer
Oral cancer symptoms can be identified and treated more quickly thanks to a new blue-light device developed by UBC’s Catherine Poh
Researchers discover how to target and disable ‘bad apple’ proteins
UBC researchers have developed a technique that targets proteins that cause disease and destroys “bad apples” in the cell.
Researchers discover treatment for rare blood cancer
UBC researchers have discovered a potential new treatment for a rare blood cancer — which may help to treat other common diseases.
Hippo pathway to better cancer treatment?
UBC researchers have discovered a potential new pathway to treat cancer by asking some odd questions about the size of animals.
UBC project examines the LGBT experience with breast and gynecological cancers
Researchers at the University of British Columbia are leading the first nationwide project on how sexual and gender minorities experience cancer, highlighting previously overlooked communities’ perspectives on cancer care.
Multiple sclerosis patients have lower risk of cancer: UBC-VCH research
Multiple sclerosis (MS) patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health. The […]
UBC researchers create more powerful “lab-on-a-chip” for genetic analysis
UBC researchers have invented a silicone chip that could make genetic analysis far more sensitive, rapid, and cost-effective by allowing individual cells to fall into place like balls in a […]
Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients
The stress of scheduling chemotherapy treatments has been substantially reduced by a new technology created and implemented by a team of researchers from the Sauder School of Business at the University of British Columbia and the BC Cancer Agency.
B.C. researchers gain $3.1M for rare cancer research Terry Fox Foundation
A team of researchers from the University of British Columbia, BC Cancer Agency and Vancouver Coastal Health Research Institute has received a $3.1-million grant from Terry Fox Foundation to study genetic aspects of rare cancers.
BC Cancer Agency to lead $1.3-million program evaluating medical-isotope alternatives
Together with TRIUMF and other partners, the BC Cancer Agency (BCCA) has received a $1.3-million grant from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) to develop an alternative source of medical isotopes. The BC grant is the largest out of seven nationally funded projects.
UBC profs and BC Cancer Agency team decode entire genome of metastatic breast cancer
Prof. Sam Aparicio of Pathology and Laboratory Medicine and Canada Research Chair in Molecular Oncology, and Prof. of Medical Genetics Marco Marra, create landmark genome that illuminates cancer development and offers new hope for fighting the disease.
Depression Increases Cancer Mortality Rate
Depression can affect a cancer patient’s likelihood of survival, according to UBC researchers who have conducted the world’s first analysis of existing cancer and depression research.